Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics
Authorisation will help protect adults 60 years of age and older in 30 European countries* from RSV disease for the first time
Product deliveries scheduled in Q3 of 2023
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
Bridging the gap between histopathology and molecular pathology
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
Subscribe To Our Newsletter & Stay Updated
